Radius Health (RDUS) Files $86.25M IPO
Radius Health, Inc. (Nasdaq: RDUS), filed a registration with the U.S. Securities and Exchange Commission for an Initial Public Offering of its Common Stock. The proposed maximum offering price is $86.25 million. Radius plans to list on the Nasdaq Global Market under the ticker, "RDUS."
The offering is being made through UBS Investment Bank, Leerink Swann, Cowen and Company, and Rodman & Renshaw, LLC.
Radius Health is a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
The offering is being made through UBS Investment Bank, Leerink Swann, Cowen and Company, and Rodman & Renshaw, LLC.
Radius Health is a biopharmaceutical company focused on developing new therapeutics for the treatment of osteoporosis and other women's health conditions.
Get immediate access to market moving news and alerts with StreetInsider.com Premium - FREE TRIAL!
You May Also Be Interested In
- UBS Maintains a 'Neutral' on Equity Residential (EQR); Lehman Walks Away With Archstone Stake; IPO Could Be On The Way
- FACEBOOK (FB) IPO OPENS HIGHER
- More than 87M shares of Facebook (FB) have already traded
Create E-mail Alert Related Categories
IPOsRelated Entities
UBS, Rodman & Renshaw, Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
